New publication: De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure

We were pleased to collaborate with colleagues  in Germany on this case report describing a de novo variant in SCN4A resulting in a phenotype of general muscle stiffness, severe respiratory failure, and clubfoot. While infantile onset of symptoms due to SCN4A variants is rare, this patient presented shortly after birth. Drug treatment was able to provide a marked and continuous improvement in symptoms, highlighting the importance of early diagnosis and treatments.

You can read the article on the Neuromuscular Disorders journal website here.

Pechmann A, Eckenweiler M, Schorling D, Stavropoulou D, Lochmüller H, Kirschner J.
De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure.
Neuromuscul Disord. 2019 Sep 13. PMID: 31732390

Abstract

Variants of the skeletal muscle sodium channel gene SCN4A are associated with different neuromuscular disorders including sodium channel myotonia. Here, we report an infant with a de novo variant in SCN4A presenting with neonatal onset of severe muscle stiffness with involvement of facial and lid muscles, and life threatening events with respiratory failure due to severe apnoea and thorax rigidity. The boy dramatically improved in both respiratory and motor function under carbamazepine therapy.

Picture1

Read next...

haleyozgefinal

Two Research Lab Members Receive CIHR Funding Awards!

We are excited to share that two of our research team members have received competitive funding awards from the Canadian Institutes of Health Research (CIHR)...
Hanns CRC image (1)

Dr. Hanns Lochmüller’s Canada Research Chair Renewed Through 2032

We are pleased to announce that Dr. Hanns Lochmüller’s Tier 1 Canada Research Chair (CRC) in Neuromuscular Genomics and Health has been renewed through the...
kiran scientist

Dr. Kiran Polavarapu Appointed Scientist at the CHEO Research Institute

We are delighted to congratulate Dr. Kiran Polavarapu on his appointment as Scientist at the Children’s Hospital of Eastern Ontario Research Institute (CHEO RI). This...
welcome

Meet The Lab’s New Clinical Members!

Our research team is growing! We are excited to announce three new research staff who have joined the lab this winter, as well as two...
researcher of the year 2025

Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine

We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
Holland study

New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice

Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...